Liver transplantation and pancreatic resection: A single-center experience and a review of the literature

Liver Transplantation

Volumn 15, Issue 12, 2009, Pages 1728-1737

  Stauffer, John A ^a   Steers, Jeffery L ^a,b   Bonatti, Hugo ^a,c   Dougherty, Marjorie K ^a   Aranda Michel, Jaime ^a   Dickson, Rolland C ^a   Harnois, Denise M ^a   Nguyen, Justin H ^a  

^a MAYO CLINIC   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; COTRIMOXAZOLE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; STEROID; TACROLIMUS; VALACICLOVIR;

ADENOCARCINOMA; ADENOMA; ADULT; ALCOHOL LIVER CIRRHOSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; GASTROINTESTINAL TUMOR; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLATSKIN TUMOR; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; NEUROENDOCRINE TUMOR; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS MASS; PANCREAS RESECTION; POSTOPERATIVE CARE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC DISEASES; PATIENT SELECTION; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71249085987     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21932     Document Type: Article

References (47)

1. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995;180:1-9.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699. (Pubitemid 26079803)
3. Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist 2005;10:269-281.
4. Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int 2008;21:1107-1117.
5. Alsina AE, Bartus S, Hull D, Rosson R, Schweizer RT. Liver transplant for metastatic neuroendocrine tumor. J Clin Gastroenterol 1990;12:533-537. (Pubitemid 20303414)
6. Anthuber M, Schauer R, Jauch KW, Kramling HJ, Schildberg FW. Experiences with liver transplantation and liver transplantation combined with Whipple's operation in Klatskin tumor [in German]. Langenbecks Arch Chir Suppl Kongressbd 1996;113:413-415.
7. Bramley PN, Lodge JP, Losowsky MS, Giles GR. Treatment of metastatic vipoma by liver transplantation. Clin Transplant 1990;4(pt 1):276-278; discussion 279.
8. Curtiss SI, Mor E, Schwartz ME, Sung MW, Hytiroglou P, Thung SN, et al. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg 1995;180:184-187.
9. Dousset B, Houssin D, Soubrane O, Boillot O, Baudin F, Chapuis Y. Metastatic endocrine tumors: is there a place for liver transplantation? Liver Transpl Surg 1995;1:111-117.
10. Fernandez JA, Robles R, Marin C, Hernandez Q, Sanchez Bueno F, Ramirez P, et al. Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc 2003;35:1832-1833. (Pubitemid 37093729)
11. Florman S, Toure B, Kim L, Gondolesi G, Roayaie S, Krieger N, et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004;8:208-212.
12. Frilling A, Malago M, Weber F, Paul A, Nadalin S, Sotiropoulos GC, et al. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Liver Transpl 2006;12:1089-1096. (Pubitemid 44063783)
13. Gottwald T, Koveker G, Busing M, Lauchart W, Becker HD. Diagnosis and management of metastatic gastrinoma by multimodality treatment including liver transplantation: report of a case. Surg Today 1998;28:551-558. (Pubitemid 28215735)
14. Hengst K, Nashan B, Avenhaus W, Ullerich H, Schlitt HJ, Flemming P, et al. Metastatic pancreatic vipoma: deteriorating clinical course and successful treatment by liver transplantation. Z Gastroenterol 1998;36:239-245. (Pubitemid 28172487)
15. Le Treut YP, Gregoire E, Belghiti J, Boillot O, Soubrane O, Mantion G, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant 2008;8:1205-1213. (Pubitemid 351763685)
16. Makowka L, Tzakis AG, Mazzaferro V, Teperman L, Demetris AJ, Iwatsuki S, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989;168:107-111. (Pubitemid 19074447)
17. Marin C, Robles R, Fernandez JA, Bueno FS, Ramirez P, Miras M, et al. Role of liver transplantation in the management of unresectable neuroendocrine liver metastases. Transplant Proc 2007;39:2302-2303. (Pubitemid 47418150)
18. Martin M, Tarara D, Wu YM, Ukah F, Fabrega A, Corwin C, et al. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation. Am Surg 1996;62:724-732. (Pubitemid 126751373)
19. Olausson M, Friman S, Herlenius G, Cahlin C, Nilsson O, Jansson S, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 2007;13:327-333. (Pubitemid 46444460)
20. Pascher A, Steinmuller T, Radke C, Hosten N, Wiedenmann B, Neuhaus P, et al. Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbecks Arch Surg 2000;385:265-270.
21. Ringe B, Lorf T, Dopkens K, Canelo R. Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: role of liver transplantation. World J Surg 2001;25:697-699. (Pubitemid 32531911)
22. Routley D, Ramage JK, McPeake J, Tan KC, Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg 1995;1:118-121.
23. van Vilsteren FG, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 2006;12:448-456.
24. Anthuber M, Jauch KW, Briegel J, Groh J, Schildberg FW. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg 1996;20:73-76. (Pubitemid 26006201)
25. Cherqui D, Alon R, Piedbois P, Duvoux C, Dhumeaux D, Julien M, et al. Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg 1995;82:397-398.
26. He XS, Zhang S, Zhu XF, Wang DP, Ma Y, Wang GD, et al. Orthotopic liver transplantation with hepatopancreatoduodenectomy for hilar cholangiocarcinoma. Chin Med J (Engl) 2007;120:251-253. (Pubitemid 46267973)
27. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-818; discussion 819.
28. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-458; discussion 458-461.
29. Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-271. (Pubitemid 38176362)
30. Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 2001;7:1023-1033. (Pubitemid 34023989)
31. Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, et al. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003;197:765-769. (Pubitemid 38199578)
32. Wu Y, Johlin FC, Rayhill SC, Jensen CS, Xie J, Cohen MB, et al. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 2008;14:279-286.
33. Chen HX, Yin L, Peng CH, Zhou GW, Shen BY, Chen H, et al. Abdominal cluster transplantation and management of perioperative hemodynamic changes. Hepatobiliary Pancreat Dis Int 2006;5:28-33. (Pubitemid 43298697)
34. Lang H, Schlitt HJ, Schmidt H, Flemming P, Nashan B, Scheumann GF, et al. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas-a single center experience with ten patients. Langenbecks Arch Surg 1999;384:370-377. (Pubitemid 29434427)
35. Lobe TE, Vera SR, Bowman LC, Fontanesi J, Britt LG, Gaber AO. Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg 1992;27:227-229.
36. Fridell JA, Vianna R, Mangus RS, Kazimi M, Hollinger E, Joseph Tector A. Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas. Clin Transplant 2008;22:681-684.
37. Sumida W, Kaneko K, Tainaka T, Ono Y, Kiuchi T, Ando H. Liver transplantation for multiple liver metastases from solid pseudopapillary tumor of the pancreas. J Pediatr Surg 2007;42:e27-e31. (Pubitemid 350235526)
38. Yoshizumi T, Shimada M, Soejima Y, Terashi T, Taketomi A, Maehara Y. Successful pylorus-preserving pancreaticoduodenectomy for a patient with carcinoma of the papilla Vater two years after living donor liver transplantation. Hepatogastroenterology 2007;54:941-943. (Pubitemid 46903759)
39. Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg 2007;204:356-364.
40. Smith CD, Sarr MG, vanHeerden JA. Completion pancreatectomy following pancreaticoduodenectomy: clinical experience. World J Surg 1992;16:521-524.
41. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, et al. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant 2009;23:168-173.
42. Nguyen JH, Dickson RC, Harnois DM. A decade of liver transplantation at Mayo Clinic in Florida. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 2008. Los Angeles, CA: Terasaki Foundation Laboratory; 2009:127-135.
43. Nguyen JH. Distinguishing between parenchymal and anastomotic leakage at duct-to-mucosa pancreatic reconstruction in pancreaticoduodenectomy. World J Gastroenterol 2008;14:6648-6654.
44. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13. (Pubitemid 40933766)
45. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002;73:386-394.
46. Farmer DG, Shaked A, Colonna JO II, Olthoff KM, Jurim O, Colquhoun S, et al. Radical resection combined with liver transplantation for foregut tumors. Am Surg 1993;59:806-812. (Pubitemid 24005727)
47. Wenisch HJ, Markus BH, Herrmann GH, Usadel KH, Encke A. Multi-visceral upper abdominal resection and orthotopic liver transplantation - a surgical treatment concept for regionally metastatic tumors of the endocrine pancreas. Zentralbl Chir 1992:11:334-342.